XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Operating activities:    
Net loss $ (118,679) $ (8,243)
Adjustments to reconcile net loss to cash used for operating activities:    
Depreciation and amortization 11,989 10,759
Amortization of deferred financing costs and debt discount 1,254 1,254
Impairment of intangible and long-lived assets 171 42
Share-based compensation expense 2,669 4,700
Deferred tax benefit (3,110) (6,693)
Allowance for doubtful accounts (74) 72
Reserve for inventory obsolescence 2,037 1,254
Foreign currency exchange rate (gain) loss (389) 623
Changes in cash due to:    
Receivables (5,961) (10,596)
Inventories 7,994 (120)
Prepaid expenses 4,937 (4,106)
Accounts payable 2,728 7,118
Accrued liabilities 3,188 (5,268)
Deferred revenue 3,405 3,560
Other long term assets and liabilities, net 734 (3,003)
Income taxes 60,385 (1,807)
Cash used for operating activities (26,722) (10,454)
Investing activities:    
Capital expenditures (990) (323)
Capitalized software expenditures (9,350) (8,905)
Cash paid for acquisitions   (4,350)
Other items, net (8) (11)
Cash used for investing activities (10,348) (13,589)
Financing activities:    
Taxes paid related to net share settlement of equity awards (205) (374)
Proceeds from stock options exercised 7  
Cash paid for acquisitions (500)  
Other items, net (26) (35)
Cash used for financing activities (724) (409)
Effect of exchange rate changes on cash and cash equivalents 315 (1,702)
Net decrease in cash and cash equivalents (37,479) (26,154)
Cash and cash equivalents, beginning of period 178,326 153,794
Cash and cash equivalents, end of period $ 140,847 $ 127,640